SBP solbec pharmaceuticals limited

cancer trial update, page-3

  1. skint
    5,996 Posts.
    lightbulb Created with Sketch. 162
    clock Created with Sketch.
    15/02/05
    13:27
    Post #: 792543
    Really dont know Salty . NSCLC is the biggest killer in the US I think . No other Australian bio has achieved this sort of result with a cancer drug , that I know of , in their first phase 1 trial against a mixture of refractory tumours (ie , not directed at the best targets ) . Long term survival is yet to be ascertained and the Imoxine combination work is yet to be completed .
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Veteran executive to help turn Trigg into leading US-based antimony producer
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.